高级搜索
六亚甲基二乙酰胺诱导分化治疗肺癌小结[J]. 肿瘤防治研究, 1994, 21(5): 312-312,314.
引用本文: 六亚甲基二乙酰胺诱导分化治疗肺癌小结[J]. 肿瘤防治研究, 1994, 21(5): 312-312,314.
HMBA therapy of bronchial carcinoma[J]. Cancer Research on Prevention and Treatment, 1994, 21(5): 312-312,314.
Citation: HMBA therapy of bronchial carcinoma[J]. Cancer Research on Prevention and Treatment, 1994, 21(5): 312-312,314.

六亚甲基二乙酰胺诱导分化治疗肺癌小结

HMBA therapy of bronchial carcinoma

  • 摘要: 用六亚甲基二乙酰胺对肿瘤进行化疗可以诱导肿瘤细胞分化为正常的或趋子正常的组织细胞.它不同于常规化放疗,因为后者直接杀死癌细胞.HMBA可用于治疗化疗、放疗及手术后残存的癌细胞.本文对15例晚期肺癌进行观察,结果是2例CR,2例PR,10例SD,且气短、咳嗽及疼痛症状得到控制,1例晚期肺癌生存期达28个月.HMBA被证明对肿瘤是有用的,应广泛使用以便进一步总结.

     

    Abstract: Hexamethylmelamine bisacetamide (HMBA)therapy for tumours may guidemour cells to change normal tissue cells or tend to normal tissue cells. It isand differentiate fu-different of commonchemotherapy and radiotherapy because they directly kill cancer cells. The use of HMBA can treat-ment the survival cancer cells after chemotherapy.radiotheraand surgery.cancerwas surved in this article. Theand pain was controled. Onetreatment tumours. It shouldresults is 2 CR,2PR,lOSD.e symptoms15 advanced lungof breathlessnesscoughadvanced lungbe spread usedcancersurvived 28 monthes. The HMBA is useful inin clinical so that we can summary further.

     

/

返回文章
返回